There are challenges aplenty in purification and analysis of PEGylated protein pharmaceuticals. Here are a variety of technical solutions, many concentrating on the chemistry of the linker.
Scott D. Buckel, Ph.D
Advertisement
Articles by Scott D. Buckel, Ph.D
Advertisement
Latest Updated Articles
Making Site-specific PEGylation WorkMarch 1st 2005
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
3
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
4
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
5